Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523321001121 |
_version_ | 1819064560798138368 |
---|---|
author | Chong Yuan Kaili Chang Chenyue Xu Qingquan Li Zunguo Du |
author_facet | Chong Yuan Kaili Chang Chenyue Xu Qingquan Li Zunguo Du |
author_sort | Chong Yuan |
collection | DOAJ |
first_indexed | 2024-12-21T15:32:31Z |
format | Article |
id | doaj.art-82e32564086041a19fbffe2606b84bdb |
institution | Directory Open Access Journal |
issn | 1936-5233 |
language | English |
last_indexed | 2024-12-21T15:32:31Z |
publishDate | 2021-08-01 |
publisher | Elsevier |
record_format | Article |
series | Translational Oncology |
spelling | doaj.art-82e32564086041a19fbffe2606b84bdb2022-12-21T18:58:44ZengElsevierTranslational Oncology1936-52332021-08-01148101120Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]Chong Yuan0Kaili Chang1Chenyue Xu2Qingquan Li3Zunguo Du4Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, ChinaDepartment of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, ChinaDepartment of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, ChinaDepartment of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China; Corresponding authors.Department of pathology, Huashan hospital, Fudan university, No.12 Middle Urumqi road, Shanghai, 200032, China; Corresponding authors.http://www.sciencedirect.com/science/article/pii/S1936523321001121 |
spellingShingle | Chong Yuan Kaili Chang Chenyue Xu Qingquan Li Zunguo Du Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080] Translational Oncology |
title | Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080] |
title_full | Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080] |
title_fullStr | Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080] |
title_full_unstemmed | Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080] |
title_short | Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080] |
title_sort | corrigendum to high expression of dll3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients translational oncology 14 2021 101080 |
url | http://www.sciencedirect.com/science/article/pii/S1936523321001121 |
work_keys_str_mv | AT chongyuan corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080 AT kailichang corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080 AT chenyuexu corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080 AT qingquanli corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080 AT zunguodu corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080 |